newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals Announces Reverse Stock Split

HAYWARD, Calif., Oct. 25, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in